ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31

Astrana Health, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$36.90+0.09 (+0.24%)

Close on Oct 19, 2026

Market cap: $1.84B
P/E (TTM): 45.0
Dividend yield: –

Astrana Health, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2016 2016-03-31	FY 2014 2014-01-31	FY 2013 2013-01-31	FY 2012 2012-01-31	FY 2011 2011-01-31
Revenue	3,182	2,035	1,387	1,144	774	687	561	520	44	10	7.78	5.11	3.90
Cost of Revenue	2,840	1,763	1,172	945	596	539	468	361	34	9.08	6.32	4.13	3.31
Gross Profit	342	271	215	199	178	148	93	159	10	1.41	1.46	0.98	0.58
General & Administrative	217	154	113	78	62	49	41	43	17	5.29	3.52	1.38	0.57
Operating Expenses	–	–	–	–	–	–	528	431	51	14	3.54	1.39	0.58
Total Costs & Expenses	3,103	1,945	1,302	1,040	676	607	528	431	–	–	–	–	–
Operating Income	79	89	85	104	98	81	32	88	-7.27	-3.91	-2.08	-0.41	0.00
Interest Expense	50	33	16	7.92	5.39	9.50	4.73	0.56	0.54	0.68	0.93	0.30	0.13
Interest & Investment Income	12	15	14	1.98	1.57	2.81	2.02	1.26	–	–	–	–	–
Income from Equity Investments	1.71	4.45	5.58	5.62	-4.31	3.69	-6.90	-8.13	–	–	–	–	–
Other Non-Operating Income	-39	-8.53	5.23	-18	-20	98	-6.58	-5.81	-0.98	-0.63	-6.82	-0.30	0.16
Asset Impairment Charges	0	0	0	0	0	0	1.99	3.80	0.21	–	–	0.21	–
Gain (Loss) on Investments	–	-0.14	-6.63	19	-11	100	0	0	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	0	0	-0.09	0	-0.04	-0.48	–	–	–	–
Pretax Income	40	81	90	87	78	178	26	83	-8.24	-4.54	-8.90	-0.71	-0.15
Income Tax Expense	16	31	32	41	32	56	8.17	22	-0.07	0.02	0.00	0.01	0.00
Net Income incl. Noncontrolling Interests	24	50	58	46	46	122	18	60	-8.17	-4.56	–	–	–
Minority Interest in Earnings	1.59	6.78	-2.87	0.57	-23	84	3.56	49	1.17	0.46	–	–	–
Net Income	22	43	61	45	69	38	14	11	-9.34	-5.02	-8.90	-0.72	-0.16
EPS (Basic)(per share)	0.46	0.91	1.30	1.00	1.57	1.03	0.41	0.33	-1.79	-1.37	-2.70	-0.20	-0.10
EPS (Diluted)(per share)	0.46	0.90	1.29	0.99	1.52	1.01	0.39	0.29	-1.79	-1.37	-2.70	-0.20	-0.10
Shares Outstanding (Basic, Weighted)(shares)	49	48	47	45	44	37	35	33	5.21	3.67	3.25	2.91	–
Shares Outstanding (Diluted, Weighted)(shares)	49	48	47	46	45	37	36	38	5.21	3.67	3.25	2.91	–
EBITDA	124	117	102	122	116	99	51	108	-6.91	-3.88	-2.06	-0.40	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 10.5%
Operating margin: 2.6%
Net margin: 1.1%
Return on equity, FY2025: 3.0%

Financial strength

Current ratio: 1.23
Debt to equity: 1.13
Debt to assets: 41.0%
Cash to current liabilities: 53.6%

Valuation

P/E ratio: 45.0
Price to sales: 0.48
Price to book: 2.21
Dividend yield: –